Skip to main content
. 2022 Feb 28;5(2):e2148474. doi: 10.1001/jamanetworkopen.2021.48474

Table. Characteristics of the Study Population at the Time of IUD Insertion.

Characteristic Participants, No. (%)
Full cohort (N = 326 658) Subcohort with known breastfeeding status (n = 94 817))
Person-years at risk, No. 641 427 182 738
Breastfeeding 64 186 (19.6) 64 186 (67.7)
Postpartum time of IUD insertion
0-3 d 2788 (0.9) 2647 (2.8)
4 d to ≤6wk 17 272 (5.3) 16 933 (17.9)
>6 to ≤14 wk 56 047 (17.2) 54 697 (57.7)
>14 to ≤52 wk 21 717 (6.6) 20 540 (21.7)
Nonpostpartum (>52 wk or no delivery) 228 834 (70.1) NA
Age, y
Mean (SD) 32.0 (8.3) 29.3 (5.7)
≤28 119 469 (36.6) 40 360 (42.6)
>28 to ≤36 107 871 (33.0) 44 643 (47.1)
>36 to ≤50 99 318 (30.4) 9814 (10.4)
Race and ethnicitya
Asian/Pacific Islander 38 911 (11.9) 12 335 (13.0)
Hispanic
Black 696 (0.2) 208 (0.2)
Other 56 180 (17.2) 15 066 (15.9)
White 42 501 (13.0) 20 159 (21.3)
Non-Hispanic
Black 28 323 (8.7) 7255 (7.7)
White 137 102 (42.0) 34 092 (36.0)
Other or multiple 16 357 (5.0) 4741 (5.0)
Recent smokingb 32 623 (10.0) 7519 (7.9)
BMI
Mean (SD) 28.5 (6.99) 28.7 (6.18)
Categoryc
Underweight, <18.5 3689 (1.1) 541 (0.6)
Normal weight, 18.5-24.9 113 675 (34.8) 28 587 (30.1)
Overweight, 25.0-29.9 96 181 (29.4) 32 628 (34.4)
Obesity, >30.0 107 674 (33.0) 32 883 (34.7)
Dysmenorrhea in the past year 15 266 (4.7) 2249 (2.4)
Menorrhagia in the past year 32 552 (10.0) 898 (0.9%)
Uterine fibroids 17 416 (5.3) 3617 (3.8)
Parityd
≤1 128 577 (39.4) 31 789 (33.5)
>1 148 985 (45.6) 57 376 (60.5)
Cesarean delivery any time before IUD insertione 54 295 (16.6) 25 792 (27.2)
Cesarean delivery for most recent delivery before IUD insertionf 23 245 (7.1) 22 551 (23.8)
IUD typeg
Levonorgestrel-releasing 259 234 (79.4) 72 201 (76.1)
Copper 63 664 (19.5) 22 004 (23.2)
Concomitant gynecological procedureh 26 234 (8.0) 1561 (1.6)
Indicator of difficult insertioni 29 777 (9.1) 2763 (2.9)
Annualized IUD insertions performed by clinician in previous year, mean (SD), No. 52.0 (73.70) 49.5 (79.52)
Duration of look-back period, mo
Mean (SD) 56.8 (42.3) 48.2 (35.0)
Median (IQR) [range] 46.3 (26.1-76.6) [12-435] 38.7 (23.0-64.2) [12-391]
Duration of follow-up, median (range), y 1.4 (0.0-10.3) 1.4 (0.0-10.3)

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); NA, not applicable; IUD, intrauterine device.

a

Race and ethnicity were as reported in electronic health records. The other and unknown categories included both those who self-identified as other and groups with very small numbers in this study (eg, non-Hispanic Native American and non-Hispanic American Indian or Alaska Native). Unknown or missing: postpartum cohort, 2.0%; breastfeeding cohort, 1.0%.

b

Unknown or missing: full cohort, 1.7%; breastfeeding cohort, 0.3%.

c

Unknown or missing: full cohort, 1.7%; breastfeeding cohort, 0.2%.

d

Unknown or missing: full cohort, 15.0%; breastfeeding cohort, 6.0%.

e

Unknown or missing: full cohort, 11.9%; breastfeeding cohort, 0.0%.

f

No delivery in the past year in the postpartum cohort: 70.1%.

g

Unknown or missing: full cohort, 1.2%; breastfeeding cohort, 0.6%.

h

At least 1 of the following: abortion, aspiration and curettage, dilation and curettage, excision or biopsy of cervix or uterus, ablation, colposcopy and other cervical procedures, hysteroscopy procedure, laminaria procedure, laparoscopy, lysis adhesions, myomectomy, nerve procedure, salpingectomy, or oophorectomy.

i

Including need for cervical dilation, ultrasound guidance, paracervical block, use of misoprostol, and clinician indicating difficulty.